Netspot FDA Approval History
FDA Approved: Yes (First approved June 1, 2016)
Brand name: Netspot
Generic name: gallium Ga 68 dotatate
Dosage form: Injection
Company: Advanced Accelerator Applications USA, Inc.
Treatment for: Diagnosis and Investigation
Netspot (gallium Ga 68 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors
Development timeline for Netspot
| Date | Article |
|---|---|
| Jun 1, 2016 | Approval FDA Approves Netspot (gallium Ga 68 dotatate) Imaging Agent to Detect Rare Neuroendocrine Tumors |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
